Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany.

by Ulrike Kuchenbecker, Daniela Chase, Anika Reichert, Julia Schiffner-Rohe, Mark Atwood
Published 2018-01-01

Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.

by John Edelsberg, Derek Weycker, Mark Atwood, Geoffrey Hamilton-Fairley, James R Jett
Published 2018-01-01

Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection.

by Sophie Marbaix, Willy E Peetermans, Jan Verhaegen, Lieven Annemans, Reiko Sato, Annick Mignon, Mark Atwood, Derek Weycker
Published 2018-01-01

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.

by Thomas E Delea, Derek Weycker, Mark Atwood, Dion Neame, Fabián P Alvarez, Evelyn Forget, Joanne M Langley, Ayman Chit
Published 2017-01-01